Cell culture contamination

Methods in Molecular Biology

Volumn 731, Issue , 2011, Pages 79-91

  Stacey, Glyn N ^a  

^a NONE

Author keywords

Aseptic technique; Cell culture; Contamination; Infection; Mycoplasma; Quality control; Quarantine; Virus

Indexed keywords

ANTIBIOTIC AGENT; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CONTAMINATION; CELL CULTURE; CELL LINE; CELL SUSPENSION; CLEANING; FUNGAL CONTAMINATION; HUMAN; INFECTION CONTROL; LABORATORY; LABORATORY DEVICE; LABORATORY PERSONNEL; MICROBIAL CONTAMINATION; MYCOPLASMA; MYCOPLASMOSIS; PREVENTIVE MEDICINE; PRIORITY JOURNAL; QUALITY CONTROL; VIRAL CONTAMINATION; ASEPSIS; ATTENTION; BACTERIUM CULTURE; CONTROLLED STUDY; HUMAN CELL; NONHUMAN; QUARANTINE; VIRUS; ANIMAL; DISINFECTION; EDUCATION; EQUIPMENT; MICROBIOLOGY;

MYCOPLASMA;

ANIMALS; CELL LINE; CELLS, CULTURED; DISINFECTION; EDUCATION; EQUIPMENT CONTAMINATION; HUMANS; INDICATORS AND REAGENTS; LABORATORIES; QUALITY CONTROL; QUARANTINE;

EID: 84934437620     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-80-5_7     Document Type: Article

References (44)

1. Coecke, S., Balls, M., Bowe, G., Davis, J., Gstraunthaler, G., Hartung, T., Hay, R., Merten, O-W., Price, A., Shechtman, L., Stacey, G., and Stokes, W. (2005) Guidance on Good cell culture practice: a report of the second ECVAM task force on good cell culture practice. ATLA 33, 261-287.
2. International Stem Cell Initiative, Adewumi, O., Afatoonian, B., Ahrlund-Richter, L., Amit, M., Andrews, P.W., Beighton, G., Bello, P.A., Benvenisty, N., Berry, L.S., Bevan, S., Blum, B., Brooking, J., Chen, K.G., Choo, A.B., Churchill, G.A., Corbel, M., Damjanov, I., Draper, J.S., Dvorak, P., Emanuelsson, K., Fleck, R.A., Ford, A., Gertow, K., Gertsenstein, M., Gokhale, P.J., Hamilton, R.S., Hampl, A., Healy, L.E., Hovatta, O., Hyllner, J., Imreh, M.P., Itskovitz-Eldor, J., Jackson, J., Johnson, J.L., Jones, M., Kee, K., King, B.L., Knowles, B.B., Lako, M., Lebrin, F., Mallon, B.S., Manning, D., Mayshar, Y., McKay, R.D., Michalska, A.E., Mikkola, M., Mileikovsky, M., Minger, S.L., Moore, H.D., Mummery, C.L., Nagy, A., Nakatsuji, N., O'Brien, C.M., Oh, S.K., Olsson, C., Otonkoski, T., Park, K.Y., Passier, R., Patel, H., Patel, M., Pedersen, R., Pera, M.F., Piekarczyk, M.S., Pera, R.A., Reubinoff, B.E., Robins, A.J., Rossant, J., Rugg-Gunn, P., Schulz, T.C., Semb, H., Sherrer, E.S., Siemen, H., Stacey, G.N., Stojkovic, M., Suemori, H., Szatkiewicz, J., Turetsky, T., Tuuri, T., van den Brink, S., Vintersten, K., Vuoristo, S., Ward, D., Weaver, T.A., Young, L.A. and Zhang, W. (2007) Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat. Biotechnol. 25, 803-16.
3. Center for Biologics Evaluation and Research (1993) Points to Consider in the Characterization of Cell Lines Used to Produce Biologicals, Food and Drug Administration, Bethesda, MD, available at: http://www.fda.gov/cber/.
4. International Conference on Harmonisation (1997) ICH Topic Q 5 D Quality of Biotechnological Products: Derivation and Characterisation of Cell Substrates Used for production of Biotechnological/Biological Products (CPMP/ICH/294/95), ICH Technical Coordination, European Medicines Evaluation Agency, London.
5. World Health Organisation (1998) Requirements for the Use of Animal Cells as in vitro Substrates for the Production of Biologicals (Requirements for Biological Substances No. 50). WHO Technical Report Series No. 878. Geneva: World Health Organization, Geneva.
6. Knezevic, I., Stacey, G.N., Petricciani, J.P. and Sheets, R. (2010) Evaluation of Cell Substrates for the production of biological: revision of WHO recommendations. Biologicals 38, 162-9.
7. Frommer, W., Archer, L., Boon. L., Brunius, G., Collins, C.H., Crooy, P., Doblhoff-Dier, O., Donikian, R., Economidis, J., and Frontali, C., et al. (1993) Safe Biotechnology recommendations for safe work with animal and human cell cultures concerning potential human pathogens. Appl. Micr. Biotechnol. 39, 141-147.
8. Stacey, G.N., Tyrrel, D.A. and Doyle, A. (1998) Source Materials. In: Safety in Cell and Tissues Culture, Stacey, G.N., Hambleton, P.J. and Doyle, A. Kluwer Academic Publishers, Dordrecht, Netherlands, pp 1-25.
9. Cobo, F., Stacey, G.N., Hunt, C., Cabrera, C., Nieto, A., Montes, R., Cortes, J.L., Catalina, P., Barnie, A. and Concha, A. (2005) Microbiological control in stem cell banks: approaches to standardisation. Appl. Microbiol. Biotechnol. 68, 456-66.
10. Kraft, V. and Meyer, B. (1990) Seromonitoring in small laboratory animal colonies: a fve year survey 1984-1988. Z. Versuchstierkol. 33, 29-35.
11. Lloyd, G. and Jones, N. (1984) Infection of laboratory workers with hantavirus acquired from immunocytomas propagated in laboratory rats. J. Infect. 12, 117-125.
12. Mahy, B.W., Dykewicz, C., Fisher-Hoch, S. Ostroff, S., Tipple, M. and Sanchez, A. (1991) Virus zoonoses and their potential for contamination of cell cultures. Dev. Biol. Stand. 75, 183-189.
13. Nicklas, W., Kraft, V. and Meyer, B. (1993) Contamination of transplantable tumour cell lines and monoclonal antibodies with rodent viruses. Lab. Anim. Sci., 43, 296-300.
14. Stacey, G.N. and Possee, R. (1996) Safety aspects of insect cell cultures. In: Current Applications of Cell Culture Engineering V2, Insect Cell Cultures-fundamental and applied aspects. Eds Vlak JM, de Gooijer CD, Tramper J and Mitenburger HG. Kluwer Acad Publishers, Dordrecht, Netherlands, pp 299-303.
15. Vaughn, J.L. (1991) Insect Cells: Adventitious Agents. Dev. Biol. Stand. 76, 319-324.
16. Xue, W. and Minocha, H.C. (1996) Identifcation of bovine diarrhoea virus receptor in different cell types. Vet. Microbiol. 49, 67-79.
17. Schuurman, R., van Strien, A., van Steenis, B., van der Noorda, J. and Sol, C. (1992) Bovine polyomavirus, a cell-transforming virus with fgenic potential. J. Gen. Virol. 73, 2871-2878.
18. Stacey, G.N. (2007) Risk assessment of cell culture processes. In: Medicines from Animal Cells, Eds. Stacey, G.N. and Davis, J.M., J Wiley & sons, Chichester.
19. Erickson, G.A., Bolin, S.R. and Landgraf, J.D. (1991) Viral contamination of foetal bovin serum used for tissue culture: risks and concerns. Dev. Biol. Stand. 75, 173-175.
20. Hallauer, C., Kronauer, G., and Siegl, G. (1971) Parvovirus contaminants of permanent human cell lines virus isolation from 1960-1970, Arch. Gesamte Virusforsch. 35, 80-90.
21. Fabisiak, J.P., Weiss, R.D., Powell, G.A. and Dauber, J.H. (1993) Enhanced secretion of immune-modulating cytokines by human lung fbroblasts during in vitro infection with Mycoplasma fermentans. Am. J. Respir. Cell Mol. Biol. 8, 358-364.
22. Polianskaia, G.G. and Efremova, T.N. (1993) The effect of Mycoplasma contamination and decontamination with ciprofoxacin on the karyotypic structure of the Chinese hamster V-79 lung cell line. Tsitologia 35, 71-78.
23. Lipp, M., Koch, E., Brandner, G. and Bredt, W. (1979) Simulation and prevention of ret-rovirus-specifc reactions by mycoplasmas. Med. Microbiol. Immunol. 167, 127-36.
24. Del Guidice RA and Gardella RS. (1984) Mycoplasma infection of cell culture: effects, incidence and detection, In: In vitro Monograph 5, Uses and standardisation of vertebrate cell cultures, Tissue Culture Association, Gaithersberg MD, USA, 1984, pp104-115.
25. McGarrity, G.I., Kotani, H. and Butler, G.H. (1993) Mycoplasma and tissue culture cells. In: Mycoplasmas: Molecular Biology and Pathogenesis, eds. Maniloff, J., ASM Press, pp 445-454.
26. Rottem, S. and Naot, Y. (1998) Subversion and exploitation of host cells by mycoplasma. Trends Microbiol. 6, 436-440.
27. Shimada, H. and Itoh, S. (1996) Effects of new quinolone antibacterial agents on mammalian chromosomes. J. Toxicol. Envir. Health. 47, 115-123.
28. Curry, P.T., Kropko, M.L., Garvin, J.R., Fiedler, R.D. and Thiess, J.C. (1996) In vitro induction of micronulclei and chromosome aberrations by quinolones: possible mechanisms. Mut. Res. 352, 143-150.
29. Stacey, G. and Auerbach, J. (2007) Quality control procedures for stem cell lines, In: Culture of Human Stem Cells. Eds Freshney, I.R., Stacey, G.N. and Auerbach, J.M. J Wiley & Sons, Hoboken, New Jersey, pp 1-22
30. BSEN 12469. (2000) Biotechnology. Performance criteria for microbiological safety cabinets, British Standards Institute, London, UK
31. ISO 14644-8:2006 (2006) Cleanrooms and associated controlled environments-Part 8: Classifcation of airborne molecular contamination. International Organization for Standardization (ISO), Geneva, Switzerland (http://www.iso.org/)
32. BS 2646-4 (1991) Autoclaves for sterilization in laboratories. Guide to maintenance. British Standards Institute, London, UK.
33. Fountain D., Ralston M., Higgins N., Gorlin J.B., Uhl.L., Wheeler C., Antin J.H., Churchill W.H. and Benjamin R.J. (1997) Liquid nitrogen freezers: A potential source of microbial contamination of hematopoietic stem cell components, Transfusion 37, 585-591.
34. Hawkins AE, Zuckerman MA, Briggs M, Gilson RJ, Goldstone AH, Brink NS, Tedder RS. (1996) Hepatitis B nucleotide sequence analysis: linking an outbreak of acute hepatitis B to contamination of a cryopreservation tank. J. Virol. Methods 60, 81-88.
35. Tedder, R.S., Zuckerman, M.A., Goldstone, A.H. et al. (1995) Hepatitis B transmission from a contaminated cryopreservation tank, Lancet, 346, 137-140.
36. Stacey, G.N. and Masters, J.R. (2008) Cryopreservation and banking of mammalian cell lines. Nat. Protocols 3, 1981-1989.
37. Lelong-Rebel, I.H., Piemont, Y., Fabre, M. and Rebel, G. (2009) Mycobacterium avium-intracellulare contamination of mammalian cell cultures. In Vitro Cell Dev. Biol. Anim. 45, 75-90.
38. Mowles, J.M., Doyle, A., Kearns, M.J. and Cerisier, Y. (1989) Isolation of an unusual fastidious contaminant bacterium from an adherent cell line using a novel technique. Advances in animal cell biology and technology for bioprocesses, Eds., Spier, R.E., Griffths, J.B., Stephenne, J. and Crooy, P.J., Butterworths & Co., Tiptree, pp. 111-114.
39. Stacey, G.N. (2007) Quality Control of Human Stem Cell Lines. In: Human Embryonic Stem Cells (Human Cell Culture-Volume 6) Eds J. Masters, B. and Palsson, J. Thomson. Springer (Tokyo and New York), pp. 1-22.
40. Young, L, Sung, J., Stacey, G., and Masters JR. (2010) Detection of Mycoplasma in cell cultures. Nat. Protocols, in press.
41. US Food and Drugs Administration. (2005) Title 21, Code of Federal Regulations, Volume 7, revised April 2005, CFR610.12 (Sterility), FDA, Department of Health and Human Services.
42. US Food and Drugs Administration. (2005) Title 21, Code of Federal Regulations, Volume 7, revised April 2005, CFR610.30 (Test for Mycoplama), FDA, Department of Health and Human Services.
43. European Pharmacopeia. (2007). European Pharmacopeia section 2.6.1 (Sterility) (6th Edition), Supplement 8, Maisonneuve SA, Sainte Ruffne, pp. 5795-5797 (www.pheur. org).
44. European Pharmacopeia. (2007). European Pharmacopeia section 2.6.7 (Mycoplasma) (6th Edition), Supplement 6.1, Maisonneuve SA, Sainte Ruffne, pp. 3317-3322.